NEW YORK (360Dx) – The stories that 360Dx readers were most interested in during the past year covered a wide swath of topics, from new guidelines for prostate cancer screening, to a new diagnostic technology based on an old toy, and new business deals. A settlement deal reached by Theranos with federal and Arizona officials also garnered attention.
Below are the top 10 stories.
1) US Task Force Changes Guidelines for Prostate Cancer Screening
2) 'Paperfuge' Could be Used for Blood Separation, Malaria Diagnostics
3) Biodesix Inks $38M Veristrat Collaboration Deal with Chinese Firm Bioyong
4) Urine DNA Test Shows Potential for Early Bladder Cancer Detection, Danish Team Reports at AMP Global
5) MDNA Inks South Korean Distribution Deal for Prostate Cancer Test
6) Mass Spec Test Developed to Distinguish Lyme Disease From Similar Condition
7) Theranos Settles Separate Cases With CMS, Arizona Attorney General
8) Letter to Trump Says Federal Hiring Freeze May Hinder FDA
9) Interpace Eyes $4M Raise in Direct Stock Offering
10) Natera Terminates Bio-Reference Labs NIPT Distribution Agreement